Yahoo
OTC Markets OTCPK - Delayed Quote USD

Scopus BioPharma Inc. (SCPS)

0.0004 0.0000 (0.00%)
At close: October 30 at 5:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2022
12/31/2021
Total Revenue
0
0
0
Operating Expense
9,343.0140
11,714.8770
27,634.6190
Operating Income
-9,343.0140
-11,714.8770
-27,634.6190
Net Non Operating Interest Income Expense
--
0
-774.6790
Other Income Expense
--
--
1,455.8890
Pretax Income
-9,343.0140
-11,714.8770
-26,953.4090
Net Income Common Stockholders
-8,695.8240
-11,609.8270
-26,953.4090
Diluted NI Available to Com Stockholders
-8,695.8240
-11,609.8270
-26,953.4090
Basic EPS
-0.31
-0.55
-1.56
Diluted EPS
-0.31
-0.55
-1.56
Basic Average Shares
28,088.1040
21,094.2640
17,252.3910
Diluted Average Shares
28,088.1040
21,094.2640
17,252.3910
Total Operating Income as Reported
--
-11,714.8770
-27,634.6190
Total Expenses
9,343.0140
11,714.8770
27,634.6190
Net Income from Continuing & Discontinued Operation
-8,695.8240
-11,609.8270
-26,953.4090
Normalized Income
-8,695.8240
-11,609.8270
-28,409.2980
Interest Expense
--
0
774.6790
Net Interest Income
--
0
-774.6790
EBIT
-9,343.0140
-11,714.8770
-26,178.7300
EBITDA
-9,341.9120
-11,713.1490
-26,177.2300
Reconciled Depreciation
1.1020
1.7280
1.5000
Net Income from Continuing Operation Net Minority Interest
-8,695.8240
-11,609.8270
-26,953.4090
Total Unusual Items Excluding Goodwill
--
--
1,455.8890
Total Unusual Items
--
--
1,455.8890
Normalized EBITDA
-9,341.9120
-11,713.1490
-27,633.1190
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
12/31/2021 - 12/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: